
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. It offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. Integra LifeSciences Holdings Corporation offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:IART
CUSIP45798520
Phone609-275-0500
Debt
Debt-to-Equity Ratio1.85%
Current Ratio2.36%
Quick Ratio1.51%
Price-To-Earnings
Trailing P/E Ratio30.80
Forward P/E Ratio25.76
P/E Growth1.69
Sales & Book Value
Annual Sales$1.19 billion
Price / Sales3.99
Cash Flow$3.4278 per share
Price / Cash17.51
Book Value$12.26 per share
Price / Book4.90
Profitability
EPS (Most Recent Fiscal Year)$1.94
Net Income$64.74 million
Net Margins5.45%
Return on Equity16.94%
Return on Assets6.27%
Miscellaneous
Employees4,400
Outstanding Shares78,960,000